These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11406188)

  • 21. The aniracetam metabolite 2-pyrrolidinone induces a long-term enhancement in AMPA receptor responses via a CaMKII pathway.
    Nishizaki T; Matsumura T
    Brain Res Mol Brain Res; 2002 Jan; 98(1-2):130-4. PubMed ID: 11834304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AMPA receptor potentiators: application for depression and Parkinson's disease.
    O'Neill MJ; Witkin JM
    Curr Drug Targets; 2007 May; 8(5):603-20. PubMed ID: 17504104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antidepressant-like actions of an AMPA receptor potentiator (LY392098).
    Li X; Tizzano JP; Griffey K; Clay M; Lindstrom T; Skolnick P
    Neuropharmacology; 2001 Jun; 40(8):1028-33. PubMed ID: 11406194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thiocyanate ions inhibit AMPA-activated currents in recombinant non-NMDA receptors expressed in Xenopus laevis oocytes: the role of the GluR2 subunit.
    Eugène D; Moss SJ; Smart TG
    Eur J Neurosci; 1996 Sep; 8(9):1983-93. PubMed ID: 8921289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allosteric regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionate receptors by thiocyanate and cyclothiazide at a common modulatory site distinct from that of 2,3-benzodiazepines.
    Donevan SD; Rogawski MA
    Neuroscience; 1998 Dec; 87(3):615-29. PubMed ID: 9758228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subtype-specific effects of lithium on glutamate receptor function.
    Karkanias NB; Papke RL
    J Neurophysiol; 1999 Apr; 81(4):1506-12. PubMed ID: 10200187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resolution, configurational assignment, and enantiopharmacology of 2-amino-3-[3-hydroxy-5-(2-methyl-2H- tetrazol-5-yl)isoxazol-4-yl]propionic acid, a potent GluR3- and GluR4-preferring AMPA receptor agonist.
    Vogensen SB; Jensen HS; Stensbøl TB; Frydenvang K; Bang-Andersen B; Johansen TN; Egebjerg J; Krogsgaard-Larsen P
    Chirality; 2000 Nov; 12(10):705-13. PubMed ID: 11054828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological characterization of cGMP regulation by the biarylpropylsulfonamide class of positive, allosteric modulators of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors.
    Ryder JW; Falcone JF; Manro JR; Svensson KA; Merchant KM
    J Pharmacol Exp Ther; 2006 Oct; 319(1):293-8. PubMed ID: 16803862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resolution, absolute stereochemistry and molecular pharmacology of the enantiomers of ATPA.
    Stensbøl TB; Borre L; Johansen TN; Egebjerg J; Madsen U; Ebert B; Krogsgaard-Larsen P
    Eur J Pharmacol; 1999 Sep; 380(2-3):153-62. PubMed ID: 10513575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular mechanisms of neurite growth with AMPA receptor potentiation.
    Voss OP; Milne S; Sharkey J; O'Neill MJ; McCulloch J
    Neuropharmacology; 2007 Feb; 52(2):590-7. PubMed ID: 17101156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allosteric interactions between cyclothiazide and AMPA/kainate receptor antagonists.
    Yamada KA; Turetsky DM
    Br J Pharmacol; 1996 Apr; 117(8):1663-72. PubMed ID: 8732274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The contributions of GluR2 to allosteric modulation of AMPA receptors.
    Cotton JL; Partin KM
    Neuropharmacology; 2000; 39(1):21-31. PubMed ID: 10665816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential desensitization of ionotropic non-NMDA receptors having distinct neuronal location and function.
    Pittaluga A; Bonfanti A; Raiteri M
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):29-38. PubMed ID: 9228187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological differentiation between neuronal and recombinant glutamate receptor channels expressed in Xenopus oocytes.
    Blaschke M; Gremmels D; Everts I; Weigand E; Heinemann SF; Hollmann M; Keller BU
    Neuropharmacology; 1997; 36(11-12):1489-501. PubMed ID: 9517419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The lethal expression of the GluR2flip/GluR4flip AMPA receptor in HEK293 cells.
    Iizuka M; Nishimura S; Wakamori M; Akiba I; Imoto K; Barsoumian EL
    Eur J Neurosci; 2000 Nov; 12(11):3900-8. PubMed ID: 11069585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kinetic properties of human AMPA-type glutamate receptors expressed in HEK293 cells.
    Grosskreutz J; Zoerner A; Schlesinger F; Krampfl K; Dengler R; Bufler J
    Eur J Neurosci; 2003 Mar; 17(6):1173-8. PubMed ID: 12670305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A desensitization-selective potentiator of AMPA-type glutamate receptors.
    Sekiguchi M; Nishikawa K; Aoki S; Wada K
    Br J Pharmacol; 2002 Aug; 136(7):1033-41. PubMed ID: 12145103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LY503430, a novel alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor potentiator with functional, neuroprotective and neurotrophic effects in rodent models of Parkinson's disease.
    Murray TK; Whalley K; Robinson CS; Ward MA; Hicks CA; Lodge D; Vandergriff JL; Baumbarger P; Siuda E; Gates M; Ogden AM; Skolnick P; Zimmerman DM; Nisenbaum ES; Bleakman D; O'Neill MJ
    J Pharmacol Exp Ther; 2003 Aug; 306(2):752-62. PubMed ID: 12730350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physiological and molecular properties of AMPA/Kainate receptors expressed by striatal medium spiny neurons.
    Stefani A; Chen Q; Flores-Hernandez J; Jiao Y; Reiner A; Surmeier DJ
    Dev Neurosci; 1998; 20(2-3):242-52. PubMed ID: 9691198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological detection of AMPA receptor heterogeneity by use of two allosteric potentiators in rat hippocampal cultures.
    Sekiguchi M; Takeo J; Harada T; Morimoto T; Kudo Y; Yamashita S; Kohsaka S; Wada K
    Br J Pharmacol; 1998 Apr; 123(7):1294-303. PubMed ID: 9579722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.